Determinants of Change in the Cost-effectiveness Threshold

被引:38
作者
Paulden, Mike [1 ]
O'Mahony, James [2 ]
McCabe, Christopher [1 ]
机构
[1] Univ Alberta, Dept Emergency Med, 736 Univ Terrace,8303 112 St, Edmonton, AB T6G 2T4, Canada
[2] Trinity Coll Dublin, Sch Med, Ctr Hlth Policy & Management, Dublin, Ireland
基金
加拿大健康研究院;
关键词
cost-effectiveness analysis; economics health; economic analysis; pharmacoeconomics; resource allocation; DECISION-MAKING; NICE; ALLOCATION; LIFE;
D O I
10.1177/0272989X16662242
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The cost-effectiveness threshold in health care systems with a constrained budget should be determined by the cost-effectiveness of displacing health care services to fund new interventions. Using comparative statics, we review some potential determinants of the threshold, including the budget for health care, the demand for existing health care interventions, the technical efficiency of existing interventions, and the development of new health technologies. We consider the anticipated direction of impact that would affect the threshold following a change in each of these determinants. Where the health care system is technically efficient, an increase in the health care budget unambiguously raises the threshold, whereas an increase in the demand for existing, non-marginal health interventions unambiguously lowers the threshold. Improvements in the technical efficiency of existing interventions may raise or lower the threshold, depending on the cause of the improvement in efficiency, whether the intervention is already funded, and, if so, whether it is marginal. New technologies may also raise or lower the threshold, depending on whether the new technology is a substitute for an existing technology and, again, whether the existing technology is marginal. Our analysis permits health economists and decision makers to assess if and in what direction the threshold may change over time. This matters, as threshold changes impact the cost-effectiveness of interventions that require decisions now but have costs and effects that fall in future periods.
引用
收藏
页码:264 / 276
页数:13
相关论文
共 22 条
[1]   Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion [J].
Claxton, K ;
Sculpher, M ;
Culyer, A ;
McCabe, C ;
Briggs, A ;
Akehurst, R ;
Buxton, M ;
Brazier, J .
HEALTH ECONOMICS, 2006, 15 (01) :1-4
[2]  
Claxton K, 2015, HEALTH TECHNOL ASSES, P19
[3]   CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS? [J].
Claxton, Karl ;
Sculpher, Mark ;
Palmer, Stephen ;
Culyer, Anthony J. .
HEALTH ECONOMICS, 2015, 24 (01) :1-7
[4]   DISCOUNTING AND DECISION MAKING IN THE ECONOMIC EVALUATION OF HEALTH-CARE TECHNOLOGIES [J].
Claxton, Karl ;
Paulden, Mike ;
Gravelle, Hugh ;
Brouwer, Werner ;
Culyer, Anthony J. .
HEALTH ECONOMICS, 2011, 20 (01) :2-15
[5]  
Claxton KP, 2007, 31 CHE U YORK
[6]  
Culyer AJ, 2016, HEALTH ECON POLICY L, V1, P1
[7]   Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis [J].
Devlin, N ;
Parkin, D .
HEALTH ECONOMICS, 2004, 13 (05) :437-452
[8]   Can the Real Opportunity Cost Stand Up: Displaced Services, the Straw Man Outside the Room [J].
Eckermann, Simon ;
Pekarsky, Brita .
PHARMACOECONOMICS, 2014, 32 (04) :319-325
[9]   Use of cost-effectiveness analysis in health-care resource allocation decision-making:: How are cost-effectiveness thresholds expected to emerge? [J].
Eichler, HG ;
Kong, SX ;
Gerth, WC ;
Mavros, P ;
Jönsson, B .
VALUE IN HEALTH, 2004, 7 (05) :518-528
[10]   Incremental cost-effectiveness ratios (ICERs): The silence of the lambda [J].
Gafni, A ;
Birch, S .
SOCIAL SCIENCE & MEDICINE, 2006, 62 (09) :2091-2100